Healthcare & Medical Devices Global On demand · 24-48h

Global Spirometry Machine Market Strategic Research Report

Global Spirometry Machine Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Spirometry Machine Market
$9542025
6.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Desktop Spirometer, Portable Spirometer

By Application: Hospital, Homecare, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Vyaire Medical, Schiller, CHEST. MI., MIR, Vitalograph, MGC, Futuremed, Fukuda Sangyo, Cosmed, Medikro, ndd Medical, M&B Electronic, Benson Medical, CONTEC

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 115 pages
Market size 2025
$954
Million USD
Forecast CAGR
6.6%
2025-2032
Forecast 2032
$1492.3
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Spirometry Machine market size is predicted to grow from US$ 954 million in 2025 to US$ 1,480 million in 2032; it is expected to grow at a CAGR of 6.6% from 2026 to 2032.

Spirometry Machine is a medical device used to measure lung function. It is a type of pulmonary function test (PFT) that measures the amount and speed of air that a person can inhale and exhale. The electronic spirometer is designed to measure both the volume and flow of air in and out of the lungs, and it provides an objective measure of lung function. Electronic spirometry is commonly used to diagnose and monitor lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. It is also used to evaluate the effects of medication and other treatments on lung function, and to assess the severity of lung disease. Electronic spirometers are preferred over traditional spirometers, as they offer greater accuracy, reproducibility, and ease of use. They are widely available in hospitals, clinics, and can be used by healthcare professionals or trained patients at home.

The spirometer market is being driven by various factors, including the increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), the growing awareness about the importance of early diagnosis and monitoring of lung function, and the technological advancements in electronic spirometry devices. Additionally, the rising geriatric population and the consequent increase in the number of patients suffering from respiratory disorders are expected to further drive the market growth. Despite the growth prospects, the electronic spirometer market faces certain limitations that may impede its growth in the coming years. One of the major challenges is the high cost of electronic spirometry devices, which makes them unaffordable for many patients, particularly in developing economies. Moreover, the lack of trained professionals who can operate and interpret spirometry tests accurately poses a significant challenge to the widespread adoption of electronic spirometry devices. Additionally, the availability of alternative diagnostic tools, such as peak flow meters and handheld spirometry devices, may also hinder the market growth to some extent. Lastly, concerns related to data privacy and security may also pose a challenge to the adoption of electronic spirometry devices, particularly in regions with strict data protection regulations.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Spirometry Machine market?

What factors are driving Spirometry Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Spirometry Machine market opportunities vary by end market size?

How does Spirometry Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Spirometry Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Desktop Spirometer
  • Portable Spirometer

Segment by Application

  • Hospital
  • Homecare
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Spirometry Machine market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital, Homecare, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Spirometry Machine Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$954
2025
Forecast
$1492.3
2032
CAGR
6.6%
2025–2032
Regiones
5
global
Key companies
Vyaire MedicalSchillerCHEST. MI.MIRVitalographMGCFuturemedFukuda Sangyo
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Desktop SpirometerPortable Spirometer
By Application
HospitalHomecareOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Desktop Spirometer
  • 3.1.3 Portable Spirometer
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital
  • 4.1.3 Homecare
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Vyaire Medical
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Schiller
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 CHEST. MI.
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 MIR
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Vitalograph
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 MGC
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Futuremed
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Fukuda Sangyo
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Cosmed
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Medikro
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 ndd Medical
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 M&B Electronic
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Benson Medical
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 CONTEC
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Spirometry Machine market?
The global Spirometry Machine market is estimated at US$ 954 million in 2025 (base year) and is projected to reach US$ 1.48 billion by 2032.
What is the forecast CAGR for the Spirometry Machine market?
The market is expected to grow at a CAGR of 6.6% from 2026 to 2032, expanding from US$ 954 million in 2025 to US$ 1.48 billion in 2032, roughly 1.6 times its base-year value.
What is Spirometry Machine?
Spirometry Machine is a medical device used to measure lung function. It is a type of pulmonary function test (PFT) that measures the amount and speed of air that a person can inhale and exhale. The electronic spirometer is designed to measure both the volume and flow of air in and out of the lungs, and it provides an objective measure of lung function.
What are the main segments of the Spirometry Machine market by type?
By type, the market is segmented into Desktop Spirometer and Portable Spirometer.
Which applications drive demand in the Spirometry Machine market?
Key applications covered include Hospital, Homecare and Other.
Who are the key players in the Spirometry Machine market?
Key players profiled include Vyaire Medical, Schiller, CHEST. MI., MIR, Vitalograph, MGC, Futuremed and Fukuda Sangyo, among 14 companies covered in total.
Which regions and countries are covered for Spirometry Machine?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Spirometry Machine market?
The spirometer market is being driven by various factors, including the increasing prevalence of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), the growing awareness about the importance of early diagnosis and monitoring of lung function, and the technological advancements in electronic spirometry devices.
What challenges does the Spirometry Machine market face?
Despite the growth prospects, the electronic spirometer market faces certain limitations that may impede its growth in the coming years.
Who should buy the Spirometry Machine market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital, Homecare and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Spirometry Machine market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.